The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
113226343 11322634 3 F 20150722 20160824 20150730 20160830 EXP IT-ROCHE-1614636 ROCHE 54.39 YR F Y 100.00000 KG 20160830 OT IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
113226343 11322634 1 PS HERCEPTIN TRASTUZUMAB 1 Intravenous (not otherwise specified) 150 MG -1 VIAL FOR INTRAVENOUS USE Y N1031B03 103792 800 MG SOLUTION FOR INFUSION /cycle
113226343 11322634 2 C OMEPRAZOLE. OMEPRAZOLE 1 Oral 0 20 MG TABLET
113226343 11322634 3 C DEXAMETHASONE PHOSPHATE DEXAMETHASONE PHOSPHATE 1 Unknown 0 12 MG SOLUTION FOR INFUSION
113226343 11322634 4 C DEXAMETHASONE PHOSPHATE DEXAMETHASONE PHOSPHATE 1 Oral 0 2 MG QD
113226343 11322634 5 C DEXAMETHASONE PHOSPHATE DEXAMETHASONE PHOSPHATE 1 Intravenous (not otherwise specified) 0 4 MG QOD
113226343 11322634 6 C DEXAMETHASONE PHOSPHATE DEXAMETHASONE PHOSPHATE 1 Intravenous (not otherwise specified) 0 12 MG
113226343 11322634 7 C ONDANSETRON HYDROCHLORIDE. ONDANSETRON HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0 8 MG SOLUTION FOR INJECTION
113226343 11322634 8 C DOCETAXEL. DOCETAXEL 1 Intravenous drip 10 MG/ML- 1 X 160 MG/16 ML VIAL 0 109 MG SOLUTION FOR INFUSION
113226343 11322634 9 C AUGMENTIN AMOXICILLINCLAVULANATE POTASSIUM 1 Oral 875 MG/125 MG - 12 SACHETS 0 1750 MG
113226343 11322634 10 C LEVOXACIN LEVOFLOXACIN 1 Oral 500 MG FILM-COATED TABLETS- 5 TABLETS 0 500 MG FILM-COATED TABLET
113226343 11322634 11 C CARDIOASPIRIN ASPIRIN 1 Oral 100 MG-30 TABLETS 0 100 MG
113226343 11322634 12 C LETROZOLE. LETROZOLE 1 Oral 0 2.5 MG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
113226343 11322634 1 HER-2 positive breast cancer
113226343 11322634 2 Gastritis
113226343 11322634 3 Vomiting
113226343 11322634 7 Vomiting
113226343 11322634 8 HER-2 positive breast cancer
113226343 11322634 9 Bacterial infection
113226343 11322634 10 Bacterial infection
113226343 11322634 11 Atrial septal defect
113226343 11322634 12 HER-2 positive breast cancer

Outcome of event

Event ID CASEID OUTC COD
113226343 11322634 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
113226343 11322634 Chills
113226343 11322634 Dyspnoea
113226343 11322634 Hyperthermia
113226343 11322634 Infusion related reaction

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
113226343 11322634 1 20150722 20150722 0
113226343 11322634 2 20150702 20150722 0
113226343 11322634 3 20150626 20150722 0
113226343 11322634 4 20150716 0
113226343 11322634 5 20150720 0
113226343 11322634 6 20150722 0
113226343 11322634 7 20150722 20150722 0
113226343 11322634 8 20150722 20150722 0
113226343 11322634 9 20150720 20150722 0
113226343 11322634 10 20150720 20150722 0
113226343 11322634 11 20090101 20150722 0
113226343 11322634 12 20150714 20150722 0